WCA Hospital using Imprivata e-prescribing tool with fingerprint id
Imprivata announced that WCA Hospital in Jamestown, New York is using Imprivata Confirm ID, an e-prescribing tool with fingerprint identification support, to enable fast, secure electronic prescribing of controlled substances (EPCS).
In using Imprivata Confirm ID, WCA is able to effectively eliminate dual prescribing workflows, improve clinical efficiency, and increase patient safety.
Imprivata Confirm ID also integrates with Cerner Soarian, WCA’s EHR system, providing two-factor authentication options including fingerprint biometrics to give WCA’s providers a single, secure prescribing workflow for all medications.
The e-prescribing solution simplifies EPCS for care providers by integrating with EHRs and e-prescribing applications and offering a wide range of two-factor authentication modalities, including fingerprints, one-time password (OTP), and hard and soft tokens.
Since WCA began implementing Imprivata Confirm ID to enable EPCS and eliminate dual prescribing workflows, the hospital has experienced a 67 percent spike in its Meaningful Use electronic prescribing rates.
Additionally, Imprivata Confirm ID has also improved WCA’s clinical workflow efficiency, increased provider satisfaction, and enhanced the patient experience by enabling a single, convenient method to receive all their medications.
“Imprivata Confirm ID delivers a complete, fully integrated product that simplifies many of the regulatory requirements for EPCS and gives providers a single, seamless e-prescribing experience for all medications,” said Sean Kelly, MD, chief medical officer at Imprivata. “WCA Hospital has seen tremendous results using Imprivata Confirm ID, and we look forward to working with other forward-thinking organizations to help them achieve similar success with their EPCS initiatives.”
WCA Hospital’s Laura Josephson and Jennifer Zabala will showcase their EPCS initiative in a presentation titled “Improve Provider Efficiency and Patient Safety with e-Prescribing of Controlled Substances,” at the Cerner Health Conference in Kansas City on October 13.
Previously reported, Imprivata launched Imprivata PatientSecure, a palm vein biometrics-based patient identification solution that generates a one-to-one link between patients and their correct medical record in their healthcare provider’s electronic health record (EHR) system.